Albaad Massuot Yitzhak Ltd (ALBA) Fair Value & Analysis
Consumer Defensive · Il · Market cap 630M ILA
Fair value as of: Jun 25, 2026
Analysis
Albaad Massuot Yitzhak Ltd (ALBA) currently trades at 30.20 ILA, while our model-based Fair Value estimate is 62.10 ILA — implying the stock looks roughly 105.6% undervalued today. We read business quality at 94/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Albaad Massuot Yitzhak Ltd engages in manufacturing and marketing of wet wipes and feminine hygiene products in Israel and Europe. The company offers baby and toddler wipes; facial and cosmetic wipes, including refreshing cosmetic, exfoliating, and make-up remover wipes; disinfecting and floor wipes; and flushable wipes. It also provides feminine hygiene products comprising G2 plastic and cardboard applicator, digital/compact digital, G4 3-piece plastic applicator, and G3 sport plastic applicator; professional wipes, such as cow udder cleaning wipes, pet wipes, car wipes, restaurant wipes, sachets, and screen wipes; and plant-based and non-woven wipes under the Hydrofine brand name. The company was founded in 1985 and is based in Ashkelon, Israel. Albaad Massuot Yitzhak Ltd operates as a subsidiary of Moshav Massuot Yitzhak.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Albaad Massuot Yitzhak Ltd (ALBA) undervalued?
What is the fair value of ALBA?
What is the quality score of ALBA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.